Echocardiographic predictors of an adverse response to a nifedipine trial in primary pulmonary hypertension: Diminished left ventricular size and leftward ventricular septal bowing

Chest

Volumn 116, Issue 5, 1999, Pages 1218-1223

  Ricciardi, Mark J ^a   Bossone, Eduardo ^a   Bach, David S ^a   Armstrong, William F ^a   Rubenfire, Melvyn ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Echocardiography; Hypotension; Nifedipine; Primary pulmonary hypertension

Indexed keywords

NIFEDIPINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DIASTOLE; DRUG EFFECT; DRUG MEGADOSE; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE SIZE; HEMODYNAMICS; HUMAN; HYPOTENSION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

EID: 0032742559     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.116.5.1218     Document Type: Article

References (27)

1. 1 Rubin LJ. Primary pulmonary hypertension. N Engl J Med 1997; 336:111-117
2. 2 Rich S, Brundage BH. High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy. Circulation 1987; 76:135-141
3. 3 Rich S, Kaufman E, Levy P. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992; 327:76-81
4. 4 Barst RJ, Rubin LJ, Long WA, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension: the Primary Pulmonary Hypertension Study Group. N Engl J Med 1996; 334:296-302
5. 5 Pasque MK, Trulock EP, Cooper JD, et al. Single lung transplantation for pulmonary hypertension: single institution experience in 34 patients. Circulation 1995; 92-2252-2258
6. 6 Groves B, Badesh D, Turkevitch D, et al. Correlation of acute prostacyclin response in primary (unexplained) pulmonary hypertension with efficacy of treatment with calcium channel blockers and survival. New York, NY: Plenum Press, 1993
7. 7 Schrader BJ, Inbar S, Kaufmann L, et al. Comparison of the effects of adenosine and nifedipine in pulmonary hypertension. J Am Coll Cardiol 1992; 19:1060-1064
8. 8 Inbar S, Schrader BJ, Kaufmann E, et al. Effects of adenosine in combination with calcium channel blockers in patients with primary pulmonary hypertension. J Am Coll Cardiol 1993; 21:413-418
9. 9 Ricciardi MJ, Knight BP, Martinez FJ, et al. Inhaled nitric oxide in primary pulmonary hypertension: a safe and effective agent for predicting response to nifedipine. J Am Coll Cardiol 1998; 32:1068-1073
10. 10 Sitbon O, Brenot F, Denjean A, et al. Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension: a dose-response study and comparison with prostacyclin. Am J Respir Crit Care Med 1995; 151:384-389
11. 11 Weir EK, Rubin LJ, Ayres SM, et al. The acute administration of vasodilators in primary pulmonary hypertension: experience from the National Institutes of Health Registry on Primary Pulmonary Hypertension. Am Rev Respir Dis 1989; 140:1623-1630
12. 12 Packer M, Medina N, Yushak M. Adverse hemodynamic and clinical effects of calcium channel blockade in pulmonary hypertension secondary to obliterative pulmonary vascular disease. J Am Coll Cardiol 1984; 4:890-901
13. 13 Eysmann SB, Palevsky HI, Reichek N, et al. Echo/Doppler and hemodynamic correlates of vasodilator responsiveness in primary pulmonary hypertension. Chest 1991; 99:1066-1071
14. 14 Hecht SR, Berger M, Berdoff RL, et al. Use of continuous-wave Doppler ultrasound to evaluate and manage primary pulmonary hypertension. Chest 1986; 90:781-783
15. 15 Eysmann SB, Palevsky HI, Reichek N, et al. Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension. Circulation 1989; 80:353-360
16. 16 Louie EK, Rich S, Brundage BH. Doppler echocardiographic assessment of impaired left ventricular filling in patients with right ventricular pressure overload due to primary pulmonary hypertension. J Am Coll Cardiol 1986; 8:1298-1306
17. 17 Drobinski G, Botreau-Roussel P, Evans JI, et al.[Paradoxical displacement of the interventricular septum with impairment of filling of the left ventricle: echocardiographic and hemodynamic diagnosis - apropos of 3 cases]. Arch Mal Coeur Vaiss 1978; 71:9-15
18. 18 Ascah KJ, King ME, Gillam LD, et al. The effects of right ventricular hemodynamics on left ventricular configuration. Can J Cardiol 1990; 6:99-106
19. 19 Doi YL, Bishop RL, Sugiura T, et al. Midsystolic closure of the aortic valve in primary pulmonary hypertension. Chest 1981; 79:710-713
20. 20 Stojnic BB, Brecker SJ, Xiao HB, et al. Left ventricular filling characteristics in pulmonary hypertension: a new mode of ventricular interaction. Br Heart J 1992; 68:16-20
21. 21 Pandian MG, Greenwald JG, Lichtman A, et al. Pulmonary hypertension associated with echocardiographic pseudohypertrophic subaortic stenosis. Angiology 1977; 28:36-39
22. 22 Goodman DJ, Rossen RM, Popp RL. Echocardiographic pseudo-idiopathic hypertrophic subaortic stenosis. Chest 1974; 66:573-574
23. 23 Currie PJ, Seward JB, Chan KL, et al. Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients. J Am Coll Cardiol 1985; 6:750-756
24. 24 Yock PG, Popp RL. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 1984; 70:657-662
25. 25 D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med 1991; 115:343-349
26. 26 Rubin LJ, Rich S. Primary pulmonary hypertension. New York, NY: Marcel Dekker, 1997
27. 27 Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension: a national prospective study. Ann Intern Med 1987; 107:216-223